LABU Holdings Information

LABU is an equity ETF with a total of 168 individual holdings.

Total Holdings

168

Top 10 Percentage

30.90%

Asset Class

Equity

ETF Category

Trading--Leveraged Equity

Assets

508.36M

PE Ratio

n/a

Breakdown by Sector

No.	Symbol	Name	% Weight	Shares
1	n/a	Dreyfus Govt Cash Man Ins	6.65%	35,887,188
2	n/a	Goldman Finl Sq Trsry Inst 506	6.40%	34,559,954
3	n/a	S&P Biotechnology Select Industry Index Swap	4.06%	25,717
4	n/a	Cash	3.77%	20,322,670
5	n/a	S&P Biotechnology Select Industry Index Swap	2.00%	33,237
6	n/a	S&P Biotechnology Select Industry Index Swap	1.98%	15,532
7	n/a	Goldman Sachs Fin Gov 465 Institut	1.75%	9,422,419
8	n/a	S&P Biotechnology Select Industry Index Swap	1.53%	15,661
9	APLS	Apellis Pharmaceuticals, Inc.	1.47%	194,250
10	RVMD	Revolution Medicines, Inc.	1.30%	48,748
11	TVTX	Travere Therapeutics, Inc.	1.28%	164,067
12	ARWR	Arrowhead Pharmaceuticals, Inc.	1.14%	83,558
13	TWST	Twist Bioscience Corporation	1.12%	103,603
14	SMMT	Summit Therapeutics Inc.	1.11%	278,847
15	ALKS	Alkermes plc	1.09%	174,823
16	n/a	S&P Biotechnology Select Industry Index Swap	1.09%	8,962
17	TGTX	TG Therapeutics, Inc.	1.08%	173,080
18	MDGL	Madrigal Pharmaceuticals, Inc.	1.08%	11,249
19	BEAM	Beam Therapeutics Inc.	1.05%	186,154
20	APGE	Apogee Therapeutics, Inc.	1.00%	65,006
21	SRRK	Scholar Rock Holding Corporation	0.97%	112,425
22	PRAX	Praxis Precision Medicines, Inc.	0.97%	16,345
23	EXEL	Exelixis, Inc.	0.96%	116,281
24	MIRM	Mirum Pharmaceuticals, Inc.	0.95%	52,917
25	UTHR	United Therapeutics Corporation	0.94%	8,914

Showing 25 of 168 holdings

Subscribe to see the full list

As of Apr 29, 2026